课题基金 / 基金详情

Studies on the mechanism for generation of factors regulating formation and stabilization of plaques in atherosclerosis.

Studies on the mechanism for generation of factors regulating formation and stabilization of plaques in atherosclerosis.
动脉粥样硬化斑块形成和稳定调节因子产生机制的研究。
批准号:
15590079
负责人:
SATO Takashi
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005

项目摘要

项目成果

SATO Takashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study focused to investigate the mechanism for generation of factors implicated in the formation and stabilization of atherosclerotic plaques that induce acute coronary syndrome. In these respects, the mechanism for foam cell formation of macrophages, which is involved in the plaque formation, and for the production of matrix proteins and matrix metalloproteinases (MMP), which are involved in plaque stability, was investigated. The results obtained are as follows.1.Involvement of phospholipase A_2 (PLA_2) in cholesteryl ester formation was revealed in mouse peritoneal macrophages exposed to oxidized low-density lipoproteins (oxLDL). The activation of PLA_2 was evoked by the translocation to membranes in response to oxLDL. Furthermore, the type IVC PLA_2 was shown to play a role for the formation assessed by experiments with type IVA knock down cells, the cells obtained from type IVA knockout mice, and type IVC over expression cells.2.The mechanism for generating MMP-1 when human coronary artery smooth muscle cells were stimulated with oxLDL was investigated. OxLDL was demonstrated to stimulate platelet-derived growth factor receptor followed by activation of extracellular signal-regulate kinase 1/2 and AP-1. Furthermore, in human macrophages obtained by differentiation of human monocytic leukemia cell line, it was characterized that MMP-9 generation induced by oxLDL is regulated by type IVA PLA_2 activation using type IVA PLA_2 knock down cells or the cells from type IVA PLA_2 knockout mice.3.The mechanism for generation of fibronectin that is a component of fibrous caps of plaques was investigated in human mesangial cells stimulated with oxLDL. Reactive oxygen species and activation of SP-1 were associated with the generation. In addition, the generation was suppressed by an inhibitor of type IVA PLA_2 and was not generated in the cells derived from type IVA PLA_2 knockout mice, demonstrating that type IVA PLA_2 contributes to the generation.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
Biochemistry of lipids in vascular function.
血管功能中脂质的生物化学。
DOI: --
发表时间: 2004
期刊:
影响因子: --
作者: [Satoshi Akiba, (M.Alberghina, ed.)]
通讯作者: ed.)
DOI: 10.1038/sj.bjp.0705805
发表时间: 2004-06
期刊: British Journal of Pharmacology
影响因子: 7.3
作者: [S. Akiba;M. Chiba;Y. Mukaida;A. Tamura;Takashi Sato]
通讯作者: S. Akiba;M. Chiba;Y. Mukaida;A. Tamura;Takashi Sato
Translocation of phospholipase A_2 to membranes by oxidized LDL and hydroxyoctadecadienoic acid to contribute to cholesteryl ester. formation
氧化 LDL 和羟基十八碳二烯酸将磷脂酶 A_2 易位至膜,形成胆固醇酯。
DOI: --
发表时间: 2004
期刊: Biochim. Biophys. Acta 1686
影响因子: --
作者: [Satoshi Akiba, Hiromi Ii, Yukimasa Yoneda, Takashi Sato]
通讯作者: Takashi Sato
Satoshi Akiba: "Oxidized LDL activates phospholipase A_2 to supply fatty acids required for cholesterol esterification."J.Lipid Res.. 44・9. 1676-1685 (2003)
Satoshi Akiba:“氧化LDL激活磷脂酶A_2以提供胆固醇酯化所需的脂肪酸。”J.Lipid Res.. 1676-1685 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
10
    Peptide ligand screening of transthyretin protein-protein interaction inhibitor using phage display system
    • 批准号:
      16K18875
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2016
    • 负责人:
      SATO Takashi
    • 依托单位:
    Study of nanoparticles-incorporating immune modulating oligodeoxynucleotide for the treatment of lung diseases
    • 批准号:
      15K09224
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      SATO Takashi
    • 依托单位:
    Evolution of the new competition policy by the open source strategy
    • 批准号:
      25380313
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      SATO Takashi
    • 依托单位:
    Development of drugs targeting secretory inhibition of transthyretin for familial amyloidotic polyneuropathy
    • 批准号:
      24790079
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.91万
    • 财政年份:
      2012
    • 负责人:
      SATO Takashi
    • 依托单位:
    国内基金
    海外基金
    乳杆菌代谢物PolyP通过LuxS/AI-2途径调控菌斑生物膜介导的矿化失衡机制研究
    • 批准号:
      82370941
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      陈曦
    • 依托单位:
    大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
    • 批准号:
      81000086
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2010
    • 负责人:
      江立生
    • 依托单位:
    抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
    • 批准号:
      30971216
    • 项目类别:
      面上项目
    • 资助金额:
      31.0万元
    • 批准年份:
      2009
    • 负责人:
      陈文强
    • 依托单位:
    基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
    • 批准号:
      30871040
    • 项目类别:
      面上项目
    • 资助金额:
      32.0万元
    • 批准年份:
      2008
    • 负责人:
      陈文强
    • 依托单位: